7 results
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... If you see a patient ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
glucose goal 140-180 mg ... /dL Insulin Pearls ... #Mellitus #DM2 ... #pharmacology # ... #endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
increase in the dose ... an increase in dose ... mg/dl in women ... ml/min per 1.73 m2 ... evidence-based pharmacologic
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
ISF) 1800/TDD = #mg ... /dL of glucose lowered ... calculations used in dosing ... #DM1 #Pharmacology ... #Endocrinology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... months or • RFB (dose ... Please refer to the table ... Guidelines for dosing ... infections #HIVAIDS #pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
/m2, 350 mg/m2, ... and 550 mg/m2, respectively ... hypertension, diabetes ... every 3 months during ... cardiology #oncology #pharmacology